The field of oncology is continuously evolving, with new therapeutic strategies and chemical agents emerging to combat cancer more effectively. Gimeracil, identified by CAS number 103766-25-2, is a compound of significant interest due to its powerful inhibitory action on dihydropyrimidine dehydrogenase (DPD). As a specialized manufacturer and supplier of high-purity pharmaceutical intermediates in China, we are proud to contribute to this progress by making Gimeracil readily available for research and therapeutic development.

Gimeracil's core function is to inhibit DPD, an enzyme critical for the metabolic breakdown of pyrimidine-based drugs. Many cornerstone chemotherapeutic agents, such as 5-fluorouracil (5-FU), rely on pyrimidine structures. When administered alongside Gimeracil, these drugs experience a reduced rate of degradation. This leads to prolonged circulation times and sustained therapeutic levels within the body, amplifying their ability to target and eliminate cancer cells. This strategic approach enhances the overall efficacy of these established cancer treatments.

Beyond its metabolic regulatory role, Gimeracil also plays a part in enhancing the effectiveness of radiation therapy. It acts as a radiosensitizer, making cancer cells more susceptible to radiation damage. This effect is achieved by interfering with the cellular mechanisms that cancer cells use to repair DNA damage, particularly the repair of double-strand breaks through homologous recombination. By inhibiting these repair pathways, Gimeracil ensures that radiation therapy causes more significant and ultimately lethal damage to the tumor.

For researchers and pharmaceutical companies worldwide, the quality and reliability of Gimeracil are paramount. We are a leading Chinese manufacturer and supplier committed to providing Gimeracil with a minimum purity of 99%. Our manufacturing processes are governed by strict quality control measures, ensuring that each batch meets the high standards required for pharmaceutical applications. We understand that consistency is key when you buy Gimeracil for research or formulation.

Procuring Gimeracil from our company offers substantial advantages. We provide competitive pricing, especially for bulk orders, allowing research institutions and pharmaceutical firms to manage their budgets effectively. As a dedicated supplier, we offer comprehensive product information, including technical data sheets and safety data sheets, to support your evaluation and use. Our goal is to establish long-term partnerships by ensuring a stable and dependable supply of this critical compound. Consider us your go-to source for Gimeracil in China.

We invite all interested parties to contact us to discuss their specific Gimeracil needs. Whether you are looking for research quantities or larger manufacturing batches, our team is equipped to provide prompt and efficient service. We are dedicated to supporting advancements in cancer treatment by supplying high-purity Gimeracil and offering exceptional customer support. Partner with us to source your Gimeracil and advance your oncology research.

In conclusion, Gimeracil (CAS 103766-25-2) is a vital chemical intermediate with significant therapeutic potential in cancer treatment. Its role as a DPD inhibitor and radiosensitizer makes it an essential component for improving the efficacy of chemotherapy and radiation. We, as a premier Chinese manufacturer and supplier, are committed to delivering high-quality Gimeracil to facilitate groundbreaking research and drug development. Contact us to buy Gimeracil and contribute to the fight against cancer.